Abstract:The best hope for slowing the progression of Alzheimer's disease (AD) will necessitate identifying sensitive biomarkers that precede and predict future symptomatic onset, i.e., amnestic Mild Cognitive Impairment (aMCI). We previously developed surface multivariate tensor-based morphometry (mTBM) and grey matter morphology signatures as potential structural MRI AD biomarkers to study hippocampal and lateral ventricular morphology. We subsequently developed patch-based sparse coding algorithms to successfully extract the most discriminating features from MR images for predicting cognitive decline. We now use these methods on a sample balanced for APOE gene dose. From a prospective cohort study, 18 initially cognitively unimpaired adults who subsequently progressed to the clinical diagnosis of aMCI or dementia due to AD within 1.8±0.8 years (progressors) were matched for age, sex, education, and APOE4 gene dose to 20 adults who remained cognitively unimpaired for at least 4 years after baseline visits (nonprogressors). Each baseline MRI scan was segmented with FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki), the hippocampal and ventricle surfaces parameterized, and the surface multivariate morphometry statistics (MMS) consisting of mTBM and radial distance (RD) generated. A collection of overlapping patches on the surface as the initial sparse coding dictionary was constructed. Stochastic Coordinate Coding was then applied to learn a dictionary and sparse codes. The max-pooling algorithm on the newly learned high-dimensional features was used to obtain a final set of low-dimensional features. Finally, an AdaBoost classifier was applied to categorize aMCI and cognitively unimpaired individuals with 5-fold cross validation adopted to evaluate classification accuracy, sensitivity, specificity, positive and negative predictive values. The prediction result of aMCI/AD was achieved with hippocampal surface MMS features, with 100% accuracy, 100% sensitivity, 100% specificity, 100% positive and 100% negative predictive values. This compares to 79% sensitivity and 78% specificity in the same sample based on standard automated brain mapping algorithmic programs to measure hippocampal volume, and assessed via binary logistic regression, and leave-one-out procedures. While our findings should be considered preliminary, sparse coding together with the surface multivariate morphometry may be applied to individual volumetric MRIs to predict imminent progression from the preclinical to clinical stages of AD with great accuracy.

Early Prediction of Progression to Alzheimer’s Disease Using Multi-Modality Neuroimages by a Novel Ordinal Learning Model ADPacer

Early Prediction of Progression to Alzheimer's Disease using Multi-Modality Neuroimages by a Novel Ordinal Learning Model ADPacer

Predicting the Pace of MCI Progression to AD Based on Multi‐modality Neuroimaging Data by a Novel Hybrid Ordinal Learning Algorithm

Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects

HOPE: Hybrid-granularity Ordinal Prototype Learning for Progression Prediction of Mild Cognitive Impairment

Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers

Investigating Predictors of Progression from Mild Cognitive Impairment to Alzheimer’s Disease Based on Different Time Intervals

Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network

IMPROVED PREDICTION OF PROGRESSION TO CLINICAL STAGES OF ALZHEIMER’S DISEASE USING MULTIVARIATE SURFACE MORPHOMETRY OF MRI BIOMARKERS AND PATCH-BASED SPARSE CODING

A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal MRI

High-Order Multi-Task Feature Learning to Identify Longitudinal Phenotypic Markers for Alzheimer's Disease Progression Prediction.

Multi-modal Sequence Learning for Alzheimer's Disease Progression Prediction with Incomplete Variable-Length Longitudinal Data.

Machine learning on longitudinal multi-modal data enabling the understanding and prognosis of Alzheimer’s disease progression

DeepAD: A Robust Deep Learning Model of Alzheimer's Disease Progression for Real-World Clinical Applications

Multi-modal Self-paced Locality Preserving Learning for Diagnosis of Alzheimer’s Disease

MAPPING ALZHEIMER'S DISEASE PSEUDO-PROGRESSION WITH MULTIMODAL BIOMARKER TRAJECTORY EMBEDDINGS

Uncertainty-driven Modality Selection for Data-Efficient Prediction of Alzheimer’s Disease

Hybrid Multimodality Fusion with Cross-Domain Knowledge Transfer to Forecast Progression Trajectories in Cognitive Decline

Predicting changes in brain metabolism and progression from mild cognitive impairment to dementia using multitask Deep Learning models and explainable AI

Modeling disease progression via multi-task learning

Multi-modal sequence learning for Alzheimer’s disease progression prediction with incomplete variable-length longitudinal data